Accès gratuit
Numéro
Méd. Intensive Réa.
Volume 25, Novembre 2016
Néphrologie et métabolisme
Page(s) S214 - S224
Section Mise au point / Update
DOI https://doi.org/10.1007/s13546-016-1240-1
Publié en ligne 7 novembre 2016
  • Leypoldt F, Armangue T, Dalmau J (2015) Autoimmune encephalopathies. Ann N Y Acad Sci 1338:94–114 [CrossRef] [PubMed] [Google Scholar]
  • Dalmau J, Rosenfeld MR (2008) Paraneoplastic syndromes of the CNS. Lancet Neurol 7:327–40 [CrossRef] [PubMed] [Google Scholar]
  • Sonneville R, Gault N, de Montmollin E, Klein IF, Mariotte E, Chemam S, et al (2015) Clinical spectrum and outcomes of patients with encephalitis requiring intensive care. Eur J Neurol 22:6–16, e1 [CrossRef] [PubMed] [Google Scholar]
  • Gaspard N, Foreman BP, Alvarez V, Cabrera Kang C, Probasco JC, Jongeling AC, et al (2015) New-onset refractory status epilepticus: Etiology, clinical features, and outcome. Neurology 85:1604–13 [CrossRef] [PubMed] [Google Scholar]
  • Graus F, Cordon-Cardo C, Posner JB (1985) Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology 35:538–43 [CrossRef] [PubMed] [Google Scholar]
  • Dalmau J, Tüzün E, Wu H, Masjuan J, Rossi JE, Voloschin A, et al (2007) Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61:25–36 [CrossRef] [PubMed] [Google Scholar]
  • Giometto B, Grisold W, Vitaliani R, Graus F, Honnorat J, Bertolini G (2010) Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol 67:330–5 [CrossRef] [PubMed] [Google Scholar]
  • Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10:63–74 [CrossRef] [PubMed] [Google Scholar]
  • Wei YC, Liu CH, Lin JJ, Lin KJ, Huang KL, Lee TH, et al (2013) Rapid progression and brain atrophy in anti-AMPA receptor encephalitis. J Neuroimmunol 261:129–33 [CrossRef] [PubMed] [Google Scholar]
  • Naasan G, Irani SR, Bettcher BM, Geschwind MD, Gelfand JM (2014) Episodic bradycardia as neurocardiac prodrome to voltage-gated potassium channel complex/leucine-rich, glioma inactivated 1 antibody encephalitis. JAMA Neurol 71:1300–4 [CrossRef] [PubMed] [Google Scholar]
  • Thomas L, Mailles A, Desestret V, Ducray F, Mathias E, Rogemond V, et al (2014) Autoimmune N-methyl-D-aspartate receptor encephalitis is a differential diagnosis of infectious encephalitis. J Infect 68:419–25 [CrossRef] [PubMed] [Google Scholar]
  • Joubert B, Kerschen P, Zekeridou A, Desestret V, Rogemond V, Chaffois MO, et al (2015) Clinical Spectrum of Encephalitis Associated With Antibodies Against the α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor: Case Series and Review of the Literature. JAMA Neurol 72:1163–9 [CrossRef] [PubMed] [Google Scholar]
  • Carvajal-González A, Leite MI, Waters P, Woodhall M, Coutinho E, Balint B, et al (2014) Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes. Brain J Neurol 137:2178–92 [CrossRef] [PubMed] [Google Scholar]
  • Titulaer MJ, Höftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, et al (2014) Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis. Ann Neurol 75:411–28 [CrossRef] [PubMed] [Google Scholar]
  • Schmitt SE, Pargeon K, Frechette ES, Hirsch LJ, Dalmau J, Friedman D (2012) Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology 79:1094–100 [CrossRef] [PubMed] [Google Scholar]
  • Heine J, Prüss H, Bartsch T, Ploner CJ, Paul F, Finke C (2015) Imaging of autoimmune encephalitis - Relevance for clinical practice and hippocampal function. Neuroscience 309:68–83 [CrossRef] [PubMed] [Google Scholar]
  • Navarro V, Kas A, Apartis E, Chami L, Rogemond V, Levy P, et al (2016) Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis. Brain 139:1079–93 [CrossRef] [PubMed] [Google Scholar]
  • Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15:391–404 [CrossRef] [PubMed] [Google Scholar]
  • Graus F, Delattre J, Antoine J, Dalmau J, Giometto B, Grisold W, et al (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75:1135–40 [CrossRef] [PubMed] [Google Scholar]
  • Wender M (2011) Acute disseminated encephalomyelitis (ADEM). J Neuroimmunol 231:92–9 [CrossRef] [PubMed] [Google Scholar]
  • Brilot F, Dale RC, Selter RC, Grummel V, Kalluri SR, Aslam M, et al (2009) Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease. Ann Neurol 66:833–42 [CrossRef] [PubMed] [Google Scholar]
  • Mathew RM, Vandenberghe R, Garcia-Merino A, Yamamoto T, Landolfi JC, Rosenfeld MR, et al (2007) Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis. Neurology 68:900–5 [CrossRef] [PubMed] [Google Scholar]
  • Peterson K, Rosenblum MK, Kotanides H, Posner JB (1992) Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 42:1931–7 [CrossRef] [PubMed] [Google Scholar]
  • Zekeridou A, Karantoni E, Viaccoz A, Ducray F, Gitiaux C, Villega F, et al (2015) Treatment and outcome of children and adolescents with N-methyl-D-aspartate receptor encephalitis. J Neurol 262:1859–66 [CrossRef] [PubMed] [Google Scholar]
  • Viaccoz A, Honnorat J (2013) Paraneoplastic neurological syndromes: general treatment overview. Curr Treat Options Neurol 15:150–68 [CrossRef] [PubMed] [Google Scholar]
  • Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, et al (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12:157–65 [CrossRef] [PubMed] [Google Scholar]
  • Thomas A, Rauschkolb P, Gresa-Arribas N, Schned A, Dalmau JO, Fadul CE (2013) Anti-N-methyl-D-aspartate receptor encephalitis: a patient with refractory illness after 25 months of intensive immunotherapy. JAMA Neurol 70:1566–8 [PubMed] [Google Scholar]
  • Davies G, Irani SR, Coltart C, Ingle G, Amin Y, Taylor C, et al (2010) Anti-N-methyl-D-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit. Crit Care Med 38:679–82 [CrossRef] [PubMed] [Google Scholar]
  • Lapébie F-X, Kennel C, Magy L, Projetti F, Honnorat J, Pichon N, et al (2014) Potential side effect of propofol and sevoflurane for anesthesia of anti-NMDA-R encephalitis. BMC Anesthesiol 14:5 [CrossRef] [PubMed] [Google Scholar]
  • MacMahon M, Naysmith MR, McCallion S, Rhodes J, MacMahon M, Naysmith MR, et al (2013) Ketamine Infusion Associated with Improved Neurology in a Patient with NMDA Receptor Encephalitis, Ketamine Infusion Associated with Improved Neurology in a Patient with NMDA Receptor Encephalitis. Case Rep Crit Care Case Rep Crit Care 2013:e383125 [Google Scholar]
  • Höftberger R, van Sonderen A, Leypoldt F, Houghton D, Geschwind M, Gelfand J, et al (2015) Encephalitis and AMPA receptor antibodies: Novel findings in a case series of 22 patients. Neurology 84:2403–12 [CrossRef] [PubMed] [Google Scholar]
  • Lai M, Huijbers MG, Lancaster E, Graus F, Bataller L, Balice-Gordon R, et al (2010) Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 9:776–85 [CrossRef] [PubMed] [Google Scholar]
  • Irani SR, Michell AW, Lang B, Pettingill P, Waters P, Johnson MR, et al (2011) Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 69:892–900 [CrossRef] [PubMed] [Google Scholar]
  • Irani SR, Pettingill P, Kleopa KA, Schiza N, Waters P, Mazia C, et al (2012) Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol 72:241–55 [CrossRef] [PubMed] [Google Scholar]
  • Lancaster E, Huijbers MG, Bar V, Boronat A, Wong A, Martinez-Hernandez E, et al (2011) Investigations of Caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 69:303–11 [CrossRef] [PubMed] [Google Scholar]
  • Meinck HM, Thompson PD (2002) Stiff man syndrome and related conditions. Mov Disord Off J Mov Disord Soc 17:853–66 [CrossRef] [Google Scholar]
  • Whiteley AM, Swash M, Urich H (1976) Progressive encephalomyelitis with rigidity. Brain 99:27–42 [CrossRef] [PubMed] [Google Scholar]
  • Byun JI, Lee ST, Jung KH, Sunwoo JS, Moon J, Lim JA, et al (2016) Effect of Immunotherapy on Seizure Outcome in Patients with Autoimmune Encephalitis: A Prospective Observational Registry Study. PLoS One 11:e0146455 [CrossRef] [PubMed] [Google Scholar]
  • Aye MM, Kasai T, Tashiro Y, Xing HQ, Shirahama H, Mitsuda M, et al (2009) CD8 positive T-cell infiltration in the dentate nucleus of paraneoplastic cerebellar degeneration. J Neuroimmunol 208:136–40 [CrossRef] [PubMed] [Google Scholar]
  • Mikasova L, De Rossi P, Bouchet D, Georges F, Rogemond V, Didelot A, et al (2012) Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis. Brain J Neurol 135:1606–21 [CrossRef] [PubMed] [Google Scholar]
  • Lai M, Hughes EG, Peng X, Zhou L, Gleichman AJ, Shu H, et al (2009) AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 65:424–34 [CrossRef] [PubMed] [Google Scholar]
  • Ohkawa T, Fukata Y, Yamasaki M, Miyazaki T, Yokoi N, Takashima H, et al (2013) Autoantibodies to Epilepsy-Related LGI1 in Limbic Encephalitis Neutralize LGI1-ADAM22 Interaction and Reduce Synaptic AMPA Receptors. J Neurosci 33:18161–74 [CrossRef] [PubMed] [Google Scholar]
  • Manley GT, Smitt PS, Dalmau J, Posner JB (1995) Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites. Ann Neurol 38:102–10 [CrossRef] [PubMed] [Google Scholar]
  • Furneaux HM, Rosenblum MK, Dalmau J, Wong E, Woodruff P, Graus F, et al (1990) Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med 322:1844–51 [CrossRef] [PubMed] [Google Scholar]
  • Leypoldt F, Titulaer MJ, Aguilar E, Walther J, Bonstrup M, Havemeister S, et al (2013) Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: Case report. Neurology 81:1637–9 [CrossRef] [PubMed] [Google Scholar]
  • Graus F, Keime-Guibert F, Reñe R, Benyahia B, Ribalta T, Ascaso C, et al (2001) Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 124:1138–48 [CrossRef] [PubMed] [Google Scholar]
  • Honnorat J, Cartalat-Carel S, Ricard D, Camdessanche JP, Carpentier AF, Rogemond V, et al (2009) Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies. J Neurol Neurosurg Psychiatry 80:412–6 [CrossRef] [PubMed] [Google Scholar]
  • Pittock SJ, Lucchinetti CF, Lennon VA (2003) Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol 53:580–7 [CrossRef] [PubMed] [Google Scholar]
  • Hoffmann LA, Jarius S, Pellkofer HL, Schueller M, Krumbholz M, Koenig F, et al (2008) Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases. J Neurol Neurosurg Psychiatry 79:767–73 [CrossRef] [PubMed] [Google Scholar]
  • Shams’ili S, Grefkens J, de Leeuw B, van den Bent M, Hooijkaas H, van der Holt B, et al (2003) Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain J Neurol 126:1409–18 [CrossRef] [Google Scholar]
  • Bernal F, Shams’ili S, Rojas I, Sanchez-Valle R, Saiz A, Dalmau J, et al (2003) Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin’s disease. Neurology 60:230–4 [CrossRef] [PubMed] [Google Scholar]
  • Pittock SJ, Lucchinetti CF, Parisi JE, Benarroch EE, Mokri B, Stephan CL, et al (2005) Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol 58:96–107 [CrossRef] [PubMed] [Google Scholar]
  • Moon J, Lee ST, Shin JW, Byun JI, Lim JA, Shin YW, et al (2014) Non-stiff anti-amphiphysin syndrome: clinical manifestations and outcome after immunotherapy. J Neuroimmunol 274:209–14 [CrossRef] [PubMed] [Google Scholar]
  • Höftberger R, Titulaer MJ, Sabater L, Dome B, Rózsás A, Hegedus B, et al (2013) Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology 81:1500–6 [CrossRef] [PubMed] [Google Scholar]
  • Ohkawa T, Satake S, Yokoi N, Miyazaki Y, Ohshita T, Sobue G, et al (2014) Identification and characterization of GABA(A) receptor autoantibodies in autoimmune encephalitis. J Neurosci Off J Soc Neurosci 34:8151–63 [CrossRef] [Google Scholar]
  • Petit-Pedrol M, Armangue T, Peng X, Bataller L, Cellucci T, Davis R, et al (2014) Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol 13:276–86 [CrossRef] [PubMed] [Google Scholar]
  • Hülsbrink R, Hashemolhosseini S (2014) Lambert-Eaton myasthenic syndrome - diagnosis, pathogenesis and therapy. Clin Neurophysiol 125:2328–36 [CrossRef] [PubMed] [Google Scholar]
  • Saiz A, Blanco Y, Sabater L, González F, Bataller L, Casamitjana R, et al (2008) Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain J Neurol 131:2553–63 [CrossRef] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.